Audit 1766

FY End
2023-06-30
Total Expended
$4.49M
Findings
0
Programs
17
Year: 2023 Accepted: 2023-10-30
Auditor: Rsm US LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.867 Vision Research $258,663 Yes 0
93.310 Trans-Nih Research Support $178,599 Yes 0
93.859 Biomedical Research and Research Training $164,551 Yes 0
93.865 Child Health and Human Development Extramural Research $146,846 Yes 0
93.394 Cancer Detection and Diagnosis Research $146,836 Yes 0
93.855 Allergy, Immunology and Transplantation Research $128,625 Yes 0
12.910 Research and Technology Development $119,658 Yes 0
47.049 Mathematical and Physical Sciences $92,959 Yes 0
93.866 Aging Research $66,677 Yes 0
47.070 Computer and Information Science and Engineering $50,971 Yes 0
93.396 Cancer Biology Research $26,905 Yes 0
93.350 National Center for Advancing Translational Sciences $23,594 Yes 0
93.395 Cancer Treatment Research $11,955 Yes 0
11.609 Measurement and Engineering Research and Standards $10,845 Yes 0
47.074 Biological Sciences $8,155 Yes 0
93.351 Research Infrastructure Programs $2,768 Yes 0
93.837 Cardiovascular Diseases Research $1,784 Yes 0

Contacts

Name Title Type
W6Q8XJV41Z98 Kathi Stanek Auditee
6083164016 William O'Brien Auditor
No contacts on file

Notes to SEFA

Title: Non-Cash Assistance, Insurance, Loans and Loan Guarantees Outstanding Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Morgridge Institute for Research, Inc. (the Institute) under programs of the federal government for the year ended June 30, 2023. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Institute, it is not intended to, and does not, present the financial position, changes in net assets, or cash flows of the Institute. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The Institute has elected to use their federally negotiated indirect cost rate for federal awards and therefore will not elect to use 10 percent de minimis indirect cost rate. The Institute did not receive any non-cash assistance during the year ended June 30, 2023. The Institute did not have any federal insurance in effect during the year ended June 30, 2023, nor were there any loans or loan guarantees at year-end.